Metasatic Breast Cancer Hormon Positive Her 2 Negative clinical trials

Explore recruiting metasatic breast cancer hormon positive her 2 negative clinical trials.

Also recruiting in Europe

Metasatic Breast Cancer Hormon Positive Her 2 Negative trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of time of alpelisib administration, concomitant fasting and low carbohydrate diet on alpelisib toxicity and efficacy; a pilot randomized controlled phase IIb trial- ITACA

Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

Metasatic Breast Cancer Hormon Positive Her 2 Negative trials by city

Metasatic Breast Cancer Hormon Positive Her 2 Negative in Toronto Metasatic Breast Cancer Hormon Positive Her 2 Negative in Vancouver Metasatic Breast Cancer Hormon Positive Her 2 Negative in Montreal Metasatic Breast Cancer Hormon Positive Her 2 Negative in Calgary Metasatic Breast Cancer Hormon Positive Her 2 Negative in Edmonton Metasatic Breast Cancer Hormon Positive Her 2 Negative in Ottawa Metasatic Breast Cancer Hormon Positive Her 2 Negative in Winnipeg Metasatic Breast Cancer Hormon Positive Her 2 Negative in Quebec City Metasatic Breast Cancer Hormon Positive Her 2 Negative in Hamilton Metasatic Breast Cancer Hormon Positive Her 2 Negative in Kitchener Metasatic Breast Cancer Hormon Positive Her 2 Negative in London Metasatic Breast Cancer Hormon Positive Her 2 Negative in Halifax Metasatic Breast Cancer Hormon Positive Her 2 Negative in New York Metasatic Breast Cancer Hormon Positive Her 2 Negative in Los Angeles Metasatic Breast Cancer Hormon Positive Her 2 Negative in Chicago Metasatic Breast Cancer Hormon Positive Her 2 Negative in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease